全文获取类型
收费全文 | 1993048篇 |
免费 | 151097篇 |
国内免费 | 4294篇 |
专业分类
耳鼻咽喉 | 29905篇 |
儿科学 | 59083篇 |
妇产科学 | 57636篇 |
基础医学 | 281593篇 |
口腔科学 | 60599篇 |
临床医学 | 171524篇 |
内科学 | 384806篇 |
皮肤病学 | 43141篇 |
神经病学 | 160816篇 |
特种医学 | 79916篇 |
外国民族医学 | 590篇 |
外科学 | 311467篇 |
综合类 | 50763篇 |
现状与发展 | 7篇 |
一般理论 | 672篇 |
预防医学 | 145870篇 |
眼科学 | 47852篇 |
药学 | 150053篇 |
3篇 | |
中国医学 | 4115篇 |
肿瘤学 | 108028篇 |
出版年
2018年 | 17370篇 |
2015年 | 17821篇 |
2014年 | 25249篇 |
2013年 | 38656篇 |
2012年 | 50966篇 |
2011年 | 53720篇 |
2010年 | 31793篇 |
2009年 | 30534篇 |
2008年 | 51487篇 |
2007年 | 56121篇 |
2006年 | 56495篇 |
2005年 | 55019篇 |
2004年 | 53869篇 |
2003年 | 52038篇 |
2002年 | 50767篇 |
2001年 | 88678篇 |
2000年 | 91098篇 |
1999年 | 77346篇 |
1998年 | 21753篇 |
1997年 | 19941篇 |
1996年 | 19251篇 |
1995年 | 18237篇 |
1994年 | 17317篇 |
1992年 | 62584篇 |
1991年 | 60648篇 |
1990年 | 59665篇 |
1989年 | 58032篇 |
1988年 | 54302篇 |
1987年 | 53513篇 |
1986年 | 51179篇 |
1985年 | 48956篇 |
1984年 | 37298篇 |
1983年 | 31730篇 |
1982年 | 19505篇 |
1981年 | 17958篇 |
1980年 | 16708篇 |
1979年 | 36729篇 |
1978年 | 26337篇 |
1977年 | 22662篇 |
1976年 | 20594篇 |
1975年 | 22968篇 |
1974年 | 27848篇 |
1973年 | 26935篇 |
1972年 | 25741篇 |
1971年 | 24044篇 |
1970年 | 22881篇 |
1969年 | 22002篇 |
1968年 | 20281篇 |
1967年 | 18486篇 |
1966年 | 17266篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
22.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
23.
24.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
25.
26.
27.
28.
29.
30.
Prevalence of HER2 Expression and Its Correlation with Clinicopathological Parameters in Gastric or Gastroesophageal Junction Adenocarcinoma in North-East Indian Population 下载免费PDF全文
Partha S RoyTomar NyoduMunlima HazarikaB J SaikiaC BhuyanAmit InamdarC W NyutheB BorthakurJ D Sharma 《Asian Pacific journal of cancer prevention》2019,20(4):1139-1145
Objective: Human epidermal growth factor receptor 2 (erbb2/HER2) overexpression, has now been implicatedin advanced gastric and gastroesophageal junction cancers. The study was conducted to determine the rate of HER2positivity in patients with locally advanced or metastatic gastric and gastroesophageal adenocarcinoma in North-EastIndia and to assess the impact of various demographic and clinical parameters on HER2 positivity. Methods: A total of68 patients of age >18 years of gastric and gastroesophageal adenocarcinoma diagnosed on histopathological examinationfrom September 2016 to February 2018 at Dr B Borooah Cancer Institute, Assam were enrolled for the observational(epidemiological) study. All patients were subjected to the HER2 immunohistochemistry test using a FDA-approved,standardized test kit. HER2 expression was correlated with various demographic and clinicopathological parameters.Results: The overall rate of HER2 positivity in the population studied was 56% (n=38). The rate was non-significantlyhigher in male, older age group (>60 years) and Hindu population. Similarly, HER2 positivity rate was higher in patientswith well differentiated histology and was more common in patients with stage II and III diseases, but neither of theassociations is statistically significant. HER2 positivity rate was significantly higher in proximal and in GEJ tumours(56% versus 44%, P=0.002). Conclusion: HER2 overexpression was evident in 56% of the North-East Indian patientswith locally advanced and metastatic gastric and gastroesophageal adenocarcinoma. The overexpression correlatedsignificantly with primary tumour site. Routine testing of gastric and gastroesophageal tumours for HER2 expressionis recommended to provide a therapeutic advantage in Indian patients. 相似文献